Already in the first quarter of this year, three European industry associations (EFPIA, Medicines for Europe and AESGP) published a “Call for a Mutual Recognition Agreement on Good Manufacturing Practice

After a four-year investigation by the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) (and with the support of the London Regional Asset Recovery Team, RART), the owner of Guernsey-based

The European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have updated their questions and answers document on regulatory expectations for medicinal products for human use during the

The European Medicines Agency EMA has published three press releases on current EU/EMA activities in the context of the COVID-19 pandemic. Task Force to take quick and coordinated regulatory action

The European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have agreed on a series of measures to mitigate the impact of disruptions caused by